ES542817A0 - Procedimiento para preparar gluconato de 2-amino-3-etoxicar-bonil-amino-6-(p-fluoro-bencilamino)-piridina - Google Patents

Procedimiento para preparar gluconato de 2-amino-3-etoxicar-bonil-amino-6-(p-fluoro-bencilamino)-piridina

Info

Publication number
ES542817A0
ES542817A0 ES542817A ES542817A ES542817A0 ES 542817 A0 ES542817 A0 ES 542817A0 ES 542817 A ES542817 A ES 542817A ES 542817 A ES542817 A ES 542817A ES 542817 A0 ES542817 A0 ES 542817A0
Authority
ES
Spain
Prior art keywords
amino
fluoro
etoxicar
bencilamino
bonyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES542817A
Other languages
English (en)
Other versions
ES8603423A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Evonik Operations GmbH
Original Assignee
Degussa GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Degussa GmbH filed Critical Degussa GmbH
Publication of ES8603423A1 publication Critical patent/ES8603423A1/es
Publication of ES542817A0 publication Critical patent/ES542817A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
    • C07C59/10—Polyhydroxy carboxylic acids
    • C07C59/105—Polyhydroxy carboxylic acids having five or more carbon atoms, e.g. aldonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES542817A 1984-05-05 1985-05-03 Procedimiento para preparar gluconato de 2-amino-3-etoxicar-bonil-amino-6-(p-fluoro-bencilamino)-piridina Granted ES542817A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843416609 DE3416609A1 (de) 1984-05-05 1984-05-05 2-amino-3-ethoxycarbonylamino-6-(p-fluor-benzylamino)- pyridin-gluconat und pharmazeutische zubereitungen, die diese substanz enthalten

Publications (2)

Publication Number Publication Date
ES8603423A1 ES8603423A1 (es) 1985-12-16
ES542817A0 true ES542817A0 (es) 1985-12-16

Family

ID=6235001

Family Applications (1)

Application Number Title Priority Date Filing Date
ES542817A Granted ES542817A0 (es) 1984-05-05 1985-05-03 Procedimiento para preparar gluconato de 2-amino-3-etoxicar-bonil-amino-6-(p-fluoro-bencilamino)-piridina

Country Status (25)

Country Link
US (1) US4673666A (es)
EP (1) EP0160865B1 (es)
JP (1) JPS60239469A (es)
KR (1) KR850008678A (es)
AT (1) ATE33638T1 (es)
AU (1) AU4194385A (es)
BG (1) BG44537A3 (es)
CA (1) CA1263398A (es)
CS (1) CS248743B2 (es)
DD (1) DD236927A5 (es)
DE (2) DE3416609A1 (es)
DK (1) DK157016C (es)
ES (1) ES542817A0 (es)
FI (1) FI80443C (es)
GR (1) GR851065B (es)
HU (1) HU193753B (es)
IE (1) IE57766B1 (es)
IL (1) IL75086A (es)
MC (1) MC1651A1 (es)
NO (1) NO851772L (es)
PL (1) PL253202A1 (es)
PT (1) PT80386B (es)
SU (1) SU1398772A3 (es)
YU (1) YU71785A (es)
ZA (1) ZA853351B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2733151B1 (fr) * 1995-04-20 1997-05-23 Seppic Sa Composition therapeutique comprenant un antigene ou un generateur in vivo d'un compose comprenant une sequence d'acides amines
US6689370B1 (en) 1995-04-20 2004-02-10 Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
US6117432A (en) * 1995-04-20 2000-09-12 Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
US6821995B1 (en) 1999-12-01 2004-11-23 Duke University Method of treating batten disease
DE10327674A1 (de) * 2003-06-20 2005-01-05 Awd.Pharma Gmbh & Co. Kg Injizierbare Darreichungsform von Flupirtin
US20080279930A1 (en) * 2007-05-07 2008-11-13 Bernd Terhaag Controlled-Release Flupirtine Compositions, Compacts, Kits and Methods of Making and Use Thereof
WO2009152142A1 (en) * 2008-06-09 2009-12-17 Awd. Pharma Gmbh & Co. Kg Sulfonate salts of flupirtine
US8183267B2 (en) 2008-06-09 2012-05-22 Awd. Pharma Gmbh & Co. Kg Carboxylic acid salts of 2-amino-3-carbethoxyamino-6-(4-fluoro-benzylamino)-pyridine
DE102010030053A1 (de) 2010-06-14 2011-12-15 Awd.Pharma Gmbh & Co.Kg Injizierbare Darreichungsform von Flupirtin
WO2012004391A1 (en) 2010-07-09 2012-01-12 K.H.S. Pharma Holding Gmbh Process for the preparation of flupirtine maleate
CN102850265B (zh) * 2011-06-29 2015-11-25 陈小花 一种氟吡汀偶联物及其制备方法和用途
CN102351786A (zh) * 2011-11-01 2012-02-15 东南大学 一种氟吡汀丙二酸盐及其制备方法
CN103910674B (zh) * 2013-12-19 2015-12-02 天津红日药业股份有限公司 用于马来酸氟吡汀分析中的参比化合物
CN104974087A (zh) * 2015-01-30 2015-10-14 吉林修正药业新药开发有限公司 一种氟吡汀二聚体的合成方法
DE102017007385A1 (de) 2017-08-02 2019-02-07 Christoph Hoock Maleatfreie feste Arzneimittelformen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4481205A (en) * 1980-09-13 1984-11-06 Degussa Aktiengesellschaft 2-Amino-3-carbethoxyamino-6-(p-fluoro-benzylamino)-pyridine-maleate
DE3133519A1 (de) * 1980-09-13 1982-06-09 Degussa Ag, 6000 Frankfurt "2-amino-3-carbethoxyamino-6-(p-fluor-benzylamino)-pyridin-maleat"

Also Published As

Publication number Publication date
IL75086A0 (en) 1985-09-29
ES8603423A1 (es) 1985-12-16
CS248743B2 (en) 1987-02-12
ATE33638T1 (de) 1988-05-15
CA1263398A (en) 1989-11-28
SU1398772A3 (ru) 1988-05-23
JPS60239469A (ja) 1985-11-28
EP0160865A2 (de) 1985-11-13
FI80443B (fi) 1990-02-28
DK198785A (da) 1985-11-06
DK157016C (da) 1990-03-26
GR851065B (es) 1985-11-25
IE851117L (en) 1985-11-05
DK157016B (da) 1989-10-30
FI80443C (fi) 1990-06-11
PL253202A1 (en) 1986-07-15
DD236927A5 (de) 1986-06-25
IE57766B1 (en) 1993-03-24
MC1651A1 (fr) 1986-04-07
IL75086A (en) 1988-03-31
DE3416609A1 (de) 1985-11-07
ZA853351B (en) 1985-12-24
HUT37758A (en) 1986-02-28
DK198785D0 (da) 1985-05-02
DE3562242D1 (en) 1988-05-26
PT80386A (de) 1985-06-01
HU193753B (en) 1987-11-30
JPH0144185B2 (es) 1989-09-26
AU4194385A (en) 1985-11-07
FI851752A0 (fi) 1985-05-03
BG44537A3 (en) 1988-12-15
KR850008678A (ko) 1985-12-21
YU71785A (en) 1988-02-29
FI851752L (fi) 1985-11-06
US4673666A (en) 1987-06-16
EP0160865A3 (en) 1986-03-12
NO851772L (no) 1985-11-06
PT80386B (de) 1987-04-16
EP0160865B1 (de) 1988-04-20

Similar Documents

Publication Publication Date Title
NO861998L (no) Overflatebelagt gjenstand, fremgangsmaate og middel for fremstilling derav og anvendelse derav.
ES542817A0 (es) Procedimiento para preparar gluconato de 2-amino-3-etoxicar-bonil-amino-6-(p-fluoro-bencilamino)-piridina
AR230284A1 (es) Proceso para la preparacion de derivados de 1,3-dihidro-6-metil-7-hidroxifuro-(3,4-c)-piridina
ES548568A0 (es) Procedimiento para la produccion de material pigmentario.
RO91871A (ro) Procedeu pentru prepararea unor derivati de 1,4-dihidro-4-oxonaftiridina
IT8720059A0 (it) Process per la preparazione di (2,2)-paraciclofano e suoi derivati.
ES2021411B3 (es) Proceso para la preparacion de (2,2) paraciclofano.
ES2013727B3 (es) Procedimiento para la fabricacion de articulos de cerdas y articulos de cerdas fabricadas por dicho procedimiento.
EP0268996A3 (en) Lactonic degradation product, process for its preparation and its use
AR240043A1 (es) Procedimiento para preparar derivados de 2-fenoxi o feniltriometil-3-fluoralilamina.
RO93388A (ro) Procedeu pentru prepararea unor derivati de aminoalcooli
HUT36783A (en) Process for preparing 1,7-diphenyl-3-methyl-aza-7-cyano-8-methyl-nonane
RO90953A (ro) Procedeu pentru prepararea unor derivati de 2-oxindol-1-carboxamida
ES2037693T3 (es) Procedimiento mejorado para la hidrogenacion catalitica de dahnp y para la preparacion de dafhp.
ES532331A0 (es) Procedimiento para preparar derivados de 4-oxo-tiazolidin-2-iliden-acetamida
ES2017485B3 (es) Proceso para la preparacion de alfa-n-(hipoxantin-9il)pentiloxi-carbonil-arginina.
DE2961524D1 (en) Glycofuranosyl-nitrosourea derivatives, process for their manufacture and their pharmaceutical preparations
DE2966043D1 (en) Process for the preparation of oside derivatives, derivatives so obtained and their biological applications
PL292414A1 (en) Method of obtaining complexes containing s-(+)-phenylalcanic and -hydroxyalcanic acids
PT78760A (en) Process for preparing terphenyl derivatives
BR8701204A (pt) Compostos,processo para sua preparacao,aplicacao e material
IT8522035A0 (it) Procedimento di preparazionedi derivati di 6-sostituita-furo-(3,4-c)-piridina.
RO88960A (ro) Procedeu pentru prepararea unor derivati de 1,2,3,-tiadiazol-3-in-5-iliden-uree
DE3868241D1 (de) Antipsoriasis-arzneimittelzubereitung und herstellungsverfahren.
DE2964518D1 (en) Benzodioxan derivatives, process for their preparation and their therapeutical applications

Legal Events

Date Code Title Description
PC1A Transfer granted
FD1A Patent lapsed

Effective date: 20051011